Geneva Advisors’s Allergan Inc AGN Stock Holding History

Geneva Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-180,322	Closed	-$38.3M	–	760
2014 Q4	$38.3M	Sell	180,322 -14,376	-7%	-$2.86M	0.71%	53
2014 Q3	$34.7M	Sell	194,698 -44,669	-19%	-$7.42M	0.65%	61
2014 Q2	$40.5M	Buy	239,367 +216,170	+932%	+$33.7M	0.74%	54
2014 Q1	$2.88M	Buy	23,197 +18,738	+420%	+$2.28M	0.05%	172
2013 Q4	$495K	Sell	4,459 -25	-0.6%	-$2.39K	0.01%	334
2013 Q3	$406K	Buy	4,484 +5	+0.1%	+$449	0.01%	362
2013 Q2	$377K	Buy	+4,479	New	+$465K	0.01%	313

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Geneva Advisors's AGN Position: Q1 2015 in Review

Geneva Advisors sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 180,322 shares — an estimated $38.3M sold.

Geneva Advisors first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $40.5M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Geneva Advisors reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Geneva Advisors sold 180,322 Allergan Inc shares in Q1 2015, an estimated $38.3M.
Geneva Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Geneva Advisors's Allergan Inc position peaked at $40.5M in Q2 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.